Results 111 to 120 of about 2,844 (161)

Metabolic Radiosensitization by Targeting Lactate Metabolism with Microfluidic Liposomal Nanocarriers. [PDF]

ACS Biomater Sci Eng
Doherty M, Feng J, Wang T, Yin C, Byrne NM, Chambers S, Islam R, Lamprou DA, Coulter JA.   +8 more
europepmc   +1 more source

The fate of pyruvate dictates cell growth by modulating cellular redox potential. [PDF]

Elife
Toshniwal AG, Lam G, Bott AJ, Cluntun AA, Skabelund R, Nam HJ, Wisidagama DR, Thummel CS, Rutter J.   +8 more
europepmc   +1 more source

Defects in auxiliary fuel oxidation and mitochondrial pyruvate transport mark transition to overt heart failure in Tgαq*44 mice. [PDF]

J Transl Med
Olkowicz M, Jedrzejewska A, Tyrankiewicz U, Fedak FA, Berkowicz P, Kwiatkowski G, Rosales-Solano H, Roy KS, Karas A, Krol O, Tomczyk M, Smolenski RT, Pawliszyn J, Chlopicki S.   +13 more
europepmc   +1 more source

Development of novel mitochondrial pyruvate carrier inhibitors for breast cancer treatment. [PDF]

J Biol Chem
Schumacher TJ, Gardner ZS, Rumbley J, Ronayne CT, Mereddy VR.   +4 more
europepmc   +1 more source

MPC-mediated lactate production drives histone lactylation in dendritic cells to affect tumor progression and immunotherapy. [PDF]

Cell Mol Life Sci
Zhang B, Xu A, Wang H, Yan W, Zhang Q, Wang S.   +5 more
europepmc   +1 more source

Genome and methylome of the oleaginous diatom reveal genetic flexibility toward a high lipid phenotype [PDF]

core   +1 more source

Targeting mitochondrial transporters and metabolic reprogramming for disease treatment. [PDF]

J Transl Med
Anselme M, He H, Lai C, Luo W, Zhong S.
europepmc   +1 more source

Targeting mitochondrial quality control in diabetic kidney disease: emerging therapeutic opportunities. [PDF]

Ren Fail
Luo J, Lu F, Cuciureanu M, Xu X, Dong H, Gong M.   +5 more
europepmc   +1 more source

Protein lactylation in metabolic dysfunction-associated steatotic liver disease: a mechanistic review. [PDF]

Diabetol Metab Syndr
Chen H, Ye Y, He T, Li B, Wang Q.
europepmc   +1 more source

Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma. [PDF]

Neuro Oncol
Martell E, Kuzmychova H, Senthil H, Chawla U, Kaul E, Grewal A, Banerji V, Anderson CM, Venugopal C, Miller D, Werbowetski-Ogilvie TE, Singh SK, Sharif T.   +12 more
europepmc   +1 more source